Approval · Notice of Compliance 3871 · 1997
INTRON A: Notice of Compliance 3871
Issued July 2, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3871
- Date
- July 2, 1997
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Three new strengths
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | 02231651 | Cancelled Post Market |
| INTRON A | 02231652 | — |
| INTRON A | 02231653 | — |
Medicinal ingredients
- INTERFERON ALFA 2B 18,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 30,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 50,000,000 UNIT per VIAL